Sheaff Brock Investment Advisors LLC Has $659,000 Stock Position in Colgate-Palmolive (NYSE:CL)
Sheaff Brock Investment Advisors LLC reduced its position in Colgate-Palmolive (NYSE:CL) by 8.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 9,194 shares of the company’s stock after selling 795 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $659,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Parsec Financial Management Inc. lifted its holdings in Colgate-Palmolive by 0.5% during the second quarter. Parsec Financial Management Inc. now owns 30,081 shares of the company’s stock worth $2,156,000 after acquiring an additional 146 shares in the last quarter. Heritage Way Advisors LLC lifted its holdings in Colgate-Palmolive by 0.4% during the second quarter. Heritage Way Advisors LLC now owns 33,769 shares of the company’s stock worth $2,420,000 after acquiring an additional 146 shares in the last quarter. Tiemann Investment Advisors LLC lifted its holdings in Colgate-Palmolive by 2.4% during the first quarter. Tiemann Investment Advisors LLC now owns 6,455 shares of the company’s stock worth $442,000 after acquiring an additional 150 shares in the last quarter. Moloney Securities Asset Management LLC lifted its holdings in Colgate-Palmolive by 2.7% during the second quarter. Moloney Securities Asset Management LLC now owns 6,038 shares of the company’s stock worth $433,000 after acquiring an additional 157 shares in the last quarter. Finally, Lynch & Associates IN lifted its holdings in Colgate-Palmolive by 0.6% during the first quarter. Lynch & Associates IN now owns 28,930 shares of the company’s stock worth $1,983,000 after acquiring an additional 160 shares in the last quarter. 75.64% of the stock is owned by institutional investors.
In other Colgate-Palmolive news, insider Ian M. Cook sold 19,500 shares of the business’s stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $69.92, for a total transaction of $1,363,440.00. Following the transaction, the insider now owns 1,186,042 shares of the company’s stock, valued at $82,928,056.64. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP John J. Huston sold 473 shares of the company’s stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $72.93, for a total value of $34,495.89. Following the completion of the transaction, the senior vice president now directly owns 59,668 shares in the company, valued at approximately $4,351,587.24. The disclosure for this sale can be found here. In the last three months, insiders have sold 480,580 shares of company stock worth $34,582,141. Company insiders own 1.14% of the company’s stock.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.72. The firm had revenue of $3.87 billion for the quarter, compared to the consensus estimate of $3.88 billion. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The business’s revenue was down .5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 earnings per share. On average, equities research analysts predict that Colgate-Palmolive will post 2.84 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Thursday, July 18th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 2.41%. The ex-dividend date of this dividend is Wednesday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.91%.
CL has been the topic of several recent analyst reports. Jefferies Financial Group lifted their target price on Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a report on Monday, April 29th. They noted that the move was a valuation call. Morgan Stanley boosted their price target on Colgate-Palmolive from $72.00 to $74.00 and gave the company an “equal weight” rating in a report on Monday, July 29th. Piper Jaffray Companies started coverage on Colgate-Palmolive in a report on Tuesday. They issued an “overweight” rating on the stock. ValuEngine lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Argus boosted their price target on Colgate-Palmolive from $72.00 to $82.00 and gave the company a “buy” rating in a report on Tuesday, June 11th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $73.13.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Article: Candlestick
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.